CORINNA CHEN is listed as a director on 4 SEC Form D filings by 3 issuers between Aug 2021 and Sep 2023: DEBUT BIOTECHNOLOGY, INC. (San Diego, CA — other technology — 2021; $22.6M reported sold to 12 investors), Synvitrobio, Inc. (San Leandro, CA — other health care — 2023; $17.6M reported sold to 16 investors) and Huue, Inc. (Berkeley, CA — other technology — 2022; $14.6M reported sold to 11 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 2 years. Across those companies the filings report $54.8M sold in total.
Listed alongside DANIEL PHILLIPS (2 shared filings), GREGORY A. WEISS (2 shared filings), Joshua Britton (2 shared filings), Francisco Dopazo (1 shared filing), Michael Nemzek (1 shared filing) and 4 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around CORINNA. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for CORINNA CHEN and found 3 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Corinna Chen" (NY) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.